NDC 59572-711

Luspatercept

Luspatercept

Luspatercept is a Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Celgene. The primary component is Luspatercept.

• Product ID: 59572-711_0619a105-2e09-4d73-a492-8f3ad7a61ec3
• NDC: 59572-711
• Product Type: Human Prescription Drug
• Proprietary Name: Luspatercept
• Generic Name: Luspatercept
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2019-11-08
• Marketing Category: BLA / BLA
• Application Number: BLA761136
• Labeler Name: Celgene
• Substance Name: LUSPATERCEPT
• Active Ingredient Strength: 25 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 59572-711-01

1 VIAL, GLASS in 1 CARTON (59572-711-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

• Marketing Start Date: 2019-11-08
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 59572-711-01 [59572071101]

Reblozyl INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: BLA
• Application Number: BLA761136
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-11-08

Drug Details

Active Ingredients

Ingredient	Strength
LUSPATERCEPT	25 mg/1

NDC Crossover Matching brand name "Luspatercept" or generic name "Luspatercept"

NDC	Brand Name	Generic Name
59572-711	Luspatercept	Luspatercept
59572-775	Luspatercept	Luspatercept